Inflammatory Disease

·MeSH: Arthritis, Rheumatoid

20 drugs in development·16 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
azithromycin	SUNSET ISLAND GROUP (SUN)

Phase 3(1)

Drug	Company
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)

Phase 2(2)

Drug	Company
etokimab	ANAPTYSBIO, INC (ANAB)
prt2761	PORTOLA PHARMACEUTICALS INC (PTLA)

Phase 1(4)

Drug	Company
ANB101	ANAPTYSBIO, INC (ANAB)
CUE-401	Cue Biopharma, Inc. (CUE)
frtx-02	Fresh Tracks Therapeutics, Inc. (FRTX)
wtx-921	Werewolf Therapeutics, Inc. (HOWL)

Preclinical(9)

Drug	Company
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
cts-2090	Histogen Inc. (HSTO)
cts-2096	Histogen Inc. (HSTO)
EPS-3903	ENANTA PHARMACEUTICALS INC (ENTA)
ht-alz	Hoth Therapeutics, Inc. (HOTH)
KT-295	Kymera Therapeutics, Inc. (KYMR)
lb-1	ProPhase Labs, Inc. (PRPH)
lb-2	ProPhase Labs, Inc. (PRPH)
man-dex	NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Unknown(3)

Drug	Company
Next generation bispecific antibody platform	Celldex Therapeutics, Inc. (CLDX)
Remicade	Merck & Co., Inc. (MRK)
Simponi	Merck & Co., Inc. (MRK)

BioSniper tracks 20 drugs in development for Inflammatory Disease across 16 companies.

There are 1 clinical trial targeting Inflammatory Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.